Elsevier

Atherosclerosis

Volume 70, Issues 1–2, March 1988, Pages 95-105
Atherosclerosis

Research paper
Detection of the terminal complement complex in patient plasma following acute myocardial infarction

https://doi.org/10.1016/0021-9150(88)90103-7Get rights and content

Abstract

The mechanisms of inflammation responsible for the myocardial tissue damage seen after an acute myocardial infarction (AMI) have not been clearly identified. Recent lines of evidence, demonstrating depressed sera levels of individual complement components in patients after myocardial infarction, have suggested involvement of the complement (C) system in micro- and macrovascular injury subsequent to AMI. The present study assessed the role of complement as a mediator of myocardial imflammation by quantifying products of complement activation including, the terminal complement complex (TCC) the cytolytic component of the complement system, C1rC1s-C1 inhibitor complex and C3bBbP complex, formed following activation of the classical and alternative pathway, respectively, and anaphylatoxins C3a and C5a in 41 patients following AMI. Plasma TCC and C1rC1s-C1 inhibitor complex concentrations increased up to 32-fold (P < 0.001) and 8-fold (P < 0.001), respectively, while the C3bBbP complex, C3a des-Arg and C5a des-Arg each increased over 2-fold (P < 0.001) 16 h after AMI, and were only minimally detectable during non-inflammatory myocardial conditions. Furthermore, TCC concentrations increased over 150% (P < 0.001) one day after patients reinfarcted, subsequent to hospitalization for a primary AMI. These results demonstrate activation of complement after AMI and suggest that inflammatory mediators of the complement system may contribute to myocardial tissue damage during the infarction process.

References (45)

  • L. McMannus et al.

    Complement localization in ischemic baboon myocardium

    Lab. Invest.

    (1983)
  • R. Pinkard et al.

    Complement localization and mediation of ischemic injury in baboon myocardium

    J. Clin. Invest.

    (1980)
  • J. Hill et al.

    The phylogistic role of C3 leukostatic fragments in myocardial infarcts in rats

    J. Exp. Med.

    (1971)
  • P. Maroko et al.

    Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion

    J. Clin. Invest.

    (1978)
  • G. Grover et al.

    Effect of complement depletion on O2 supply and consumption in ischemic dog myocardium

    Basic Res. Cardiol.

    (1987)
  • J. Mayes et al.

    Development and application of an enzyme-linked immunosorbent assay for the quantitation of the alternative complement pathway activation in human serum

    J. Clin. Invest.

    (1984)
  • T. Hugli et al.

    Biologically active peptides of complement: techniques and significance of C3a and C5a measurement

  • S. Ruddy

    Complement

  • S. Rosalki

    An improved procedure for serum creatine phosphokinase determination

    J. Lab. Clin. Med.

    (1967)
  • R. Goldberg et al.

    Significance of the Q wave in acute myocardial infarction

    Cli. Cardiol.

    (1985)
  • G. Gerson

    Myocardial imaging in myocardial infarction: technetium vs. thallium

    Cardiovasc. Clin.

    (1983)
  • M. Wolk et al.

    Heart failure complicating acute myocardial infarction

    Circulation

    (1972)
  • Cited by (78)

    • Complement activation in acute myocardial infarction: An early marker of inflammation and tissue injury?

      2018, Immunology Letters
      Citation Excerpt :

      Later, Reyes et al. (1984) [22] showed that products of C3 degradation were presented in the plasma of AMI patients and correlated with the severe evolution and bad prognostic of AMI. Plasma concentration of native C3 and C4 [23], as well as C3d and C4d, sC5b9 [12,23], C3a and C5a [24] were also shown to be increased in AMI patients. Although several reports suggest that complement activation is crucial in the pathophysiology of cardiovascular events [25], few studies have investigated the association between serum levels of complement and AMI in a longitudinal follow-up from patient admission to discharge from the hospital.

    • A polysaccharide (PNPA) from Pleurotus nebrodensis offers cardiac protection against ischemia-reperfusion injury in rats

      2015, Carbohydrate Polymers
      Citation Excerpt :

      Over the last decade, reintroduction of blood flow to a former ischemic area was the successful logical approach for the treatment of patients with acute obstruction of coronary arteries, during which myocardial ischemia–reperfusion (I/R) injury occurs (Maxwell & Lip, 1997; Verma et al., 2002). The main mechanisms which trigger and modulate myocardial I/R injury have been well characterized, including the generation of reactive oxygen species (ROS), complement activation and inflammatory response (Kilgore & Luchessi, 1993; Langlois & Gawryl, 1998; Romson et al., 1983). Increasing evidence has proposed that the generation of ROS immediately upon reperfusion will in turn accelerate the development and progression of myocardial I/R injury (McCord, 1985).

    View all citing articles on Scopus

    Present address: Biopore, 68 Harrison Ave., Boston, MA 02111, U.S.A.

    View full text